# Flufenamic Acid for Hospitalised Influenza Infection

> **NCT03238612** · PHASE2 · UNKNOWN · sponsor: **The University of Hong Kong** · enrollment: 200 (estimated)

## Conditions studied

- Influenza A

## Interventions

- **DRUG:** FFA, clarithromycin, oseltamivir
- **DRUG:** Oseltamivir alone

## Key facts

- **NCT ID:** NCT03238612
- **Lead sponsor:** The University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-01-08
- **Primary completion:** 2020-07-31
- **Final completion:** 2020-10-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2019-10-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03238612

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03238612, "Flufenamic Acid for Hospitalised Influenza Infection". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03238612. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*